Free Trial

Cytokinetics (CYTK) SEC Filings & 10K Form

$49.40
+1.54 (+3.22%)
(As of 02:10 PM ET)

Recent Cytokinetics SEC Filings

DateFilerForm TypeView
05/22/2024
3:15 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
4:59 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:00 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:01 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:03 PM
Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:04 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:05 PM
Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:06 PM
COSTA SANTO J (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
5:17 PM
Bhanji Muna (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:00 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
6:05 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:37 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2024
4:30 PM
Cytokinetics (Issuer)
Lee Sung (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/25/2024
5:54 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
3:38 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
3:35 PM
Cytokinetics (Filer)
Form DEF 14A
04/08/2024
3:37 PM
Cytokinetics (Filer)
Form ARS
04/05/2024
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
5:57 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
6:02 PM
Callos Andrew (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
6:07 PM
Cytokinetics (Issuer)
Wong Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
5:52 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:26 PM
Cytokinetics (Issuer)
Wong Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:50 AM
Cytokinetics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/06/2024
3:43 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:38 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
3:41 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
9:45 AM
Cytokinetics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/22/2024
4:19 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
1:03 PM
BlackRock Inc. (Filed by)
Cytokinetics (Subject)
Form SC 13G/A
01/19/2024
3:49 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
4:20 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
3:09 PM
Cytokinetics (Subject)
HENDERSON JOHN T (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
3:02 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
4:55 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:19 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2023
3:10 PM
Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/27/2023
3:11 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
4:22 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
3:21 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Shocking: One AI startup's revenue could surge 4,735% (Ad)

Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.

Click here to discover the AI chip company
11/03/2023
4:30 PM
Cytokinetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2023
3:48 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/19/2023
6:32 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
4:57 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
3:18 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/12/2023
5:39 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2023
3:22 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/06/2023
3:52 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
3:32 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
3:09 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2023
3:13 PM
Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
8:06 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
3:09 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2023
3:18 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:09 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
3:09 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2023
5:45 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2023
3:33 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2023
3:38 PM
Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/11/2023
4:32 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/10/2023
4:18 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2023
3:14 PM
Cytokinetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2023
3:25 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/13/2023
6:24 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/13/2023
6:01 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/13/2023
3:09 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2023
3:10 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
4:12 PM
Bhanji Muna (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/07/2023
3:17 PM
Bhanji Muna (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:18 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:19 PM
Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:20 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2023
1:18 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2023
4:49 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2023
3:50 PM
Blum Robert I (Reporting)
Cytokinetics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/08/2023
4:47 PM
Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/08/2023
3:31 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2023
4:06 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CYTK) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners